Mark De Ridder
0000-0003-4433-8807
228 papers found
Refreshing results…
A complementary dual-modality verification for tumor tracking on a gimbaled linac system
Hypoxia Integration in the Serological Proteome Analysis Unmasks Tumor Antigens and Fosters the Identification of Anti-Phospho-eEF2 Antibodies as Potential Cancer Biomarkers
A Novel Framework for Deformable Registration Evaluation and Quality Assurance
A Novel Framework for User-Intervened Correction of Deformable Registration
Phase 2 Study of Hypofractionated Radiation Therapy in the Treatment of Oligometastatic Non-Small Cell Lung Cancer
A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
WE‐A‐134‐05: Comparison Between a Clinical Protocol and a Fast Automatic Update for Correlation Model Retraining During Gimballed Tumour Tracking: Impact On Margins and Target Dose Coverage
SU‐E‐J‐166: Combining Dynamic Wave Arc and Tangential Arc for Breast Boost Irradiation with the Vero System
SU‐E‐J‐79: Characterizing Accuracy in 4DCT Deformable Registration Using the POPI M odel
TH‐A‐137‐11: First Clinical Experience Treating Patients with the Gimbaled Linac Tumor Tracking of the Vero SBRT System
Abstract 4986: Myeloid-derived suppressor cells as a biomarker of tumor growth and radiosensitivity: Role of hypoxia-inducible arginase-1.
Abstract 421: Hypoxic radioresistance of tumor cells is sustained by M2 macrophages but can be counteracted by M1 activation resulting in nitric oxide-induced oxygen sparing.
Hepatocytes Determine the Hypoxic Microenvironment and Radiosensitivity of Colorectal Cancer Cells Through Production of Nitric Oxide That Targets Mitochondrial Respiration
Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas
Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: A patient simulation study
Myeloid cells as a novel determinant of hypoxic radioresponse in colorectal cancer cells through L-arginine turnover
A comprehensive QA programme of treatment unit and treatment planning systems would make pre-treatment verifications redundant
Stereotactic radiotherapy for oligometastatic cancer: a predictive model for survival
Preoperative radiotherapy with a simultaneous integrated boost compared to chemoradiotherapy for T3-4 rectal cancer: Interim analysis of a multicentric randomized trial
Rotational, intensity-modulated radiotherapy for inoperable non-small cell lung cancer: Long term follow-up and toxicity profile
Missing publications? Search for publications with a matching author name.